Form 8-K II-VI INC For: Nov 20
�
�
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
�
�
FORM 8-K
�
�
CURRENT REPORT PURSUANT
TO SECTION�13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) November�20, 2014
�
�
II-VI Incorporated
(Exact Name of Registrant as Specified in Its Charter)
�
�
Pennsylvania
(State or Other Jurisdiction of Incorporation)
�
0-16195 | � | 25-1214948 |
(Commission File Number) |
� | (IRS Employer Identification No.) |
�
375 Saxonburg Boulevard, Saxonburg, Pennsylvania | � | 16056 |
(Address of Principal Executive Offices) | � | (Zip Code) |
(724) 352-4455
(Registrant�s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
�
�
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
�
� | � | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
�
� | � | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
�
� | � | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
�
� | � | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
�
�
�
Item�7.01 | Regulation FD Disclosure |
On November�20, 2014, management of II-VI Incorporated (the �Company�) will be presenting at the Furey Research Partners Hidden Gem Conference investor conference in New York, N.Y. The presentation materials are attached hereto as Exhibit�99.1 and incorporated herein by reference. These materials may also be used at one or more subsequent conferences. The information contained in the attached presentation materials is summary information that is intended to be considered in the context of the Company�s SEC filings and other public announcements. The Company undertakes no duty or obligation to publicly update or revise this information, although it may do so from time to time.
The information in this Current Report on Form 8-K, including the exhibit furnished pursuant to Item�9.01, shall not be deemed �filed� for the purposes of Section�18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities under that Section. Furthermore, the information in this Current Report on Form 8-K, including the exhibit furnished pursuant to Item�9.01, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933.
�
Item�9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit 99.1 Investor conference presentation materials titled �Furey Research Partners Hidden Gem Conference� used beginning November�20, 2014.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
�
� | � | II-VI INCORPORATED (Registrant) | ||||
Date: November�20, 2014 | � | � | By: | � | /s/ Mary Jane Raymond | |
� | � | Name: | � | Mary Jane Raymond | ||
� | � | Title: | � | Chief Financial Officer |
EXHIBIT INDEX
�
Exhibit�No. |
�� | Description |
Exhibit�99.1. | �� | Furey Research Partners Hidden Gem Conference Investor Conference presentation materials used beginning November�20, 2014. |
A Global Leader
in Engineered Materials & Opto-Electronic Components
Exhibit 99.1
Furey Research Partners
Hidden Gems Conference
November 20, 2014
New York City
Our Technologies for Tomorrow�s Innovations
www.ii-vi.com������������
����� NASDAQ: IIVI |
www.ii-vi.com����� I���� NASDAQ:
IIVI 2
Matters discussed in this presentation may contain forward-looking
statements that are subject to risks and uncertainties.� These risks and
uncertainties could cause the forward-looking statements and II-VI
Incorporated�s (the Company�s) actual results to differ materially.�
In evaluating these forward-looking statements, you should specifically
consider the �Risk Factors�
in the Company�s most recent Form 10-K and
Form 10-Q. Forward-looking statements are only estimates and actual
events or results may differ materially.
II-VI Incorporated disclaims any obligation to update information contained
in any forward-looking statement.
This presentation contains certain non-GAAP financial measures.�
Reconciliations of non-GAAP financial measures to their most comparable
GAAP financial measures are presented at the end of this presentation.
Safe Harbor Statement |
3
Our Core �
Material Excellence |
Global Leader in
Engineered Materials Headquartered in Saxonburg, PA
~ 7,000 Employees in 14 Countries
FY14: $683M Revenue, 5.6% ROS
4
4 consecutive decades of profitability and counting
Fiscal Year Revenues
56%
44%
46%
22%
20%
4%
4%
4%
About II-VI
31%
32%
37% |
5
Organization
Photonics
Performance Products
Laser Solutions
M&A / Integration
Tech Management
Trade Compliance
Operation Metrics
Quality
SCM
Legal
Strategic
Resources
Corporate
G&A
R&D
NPI |
6
Revenue
TAM
Share
FY14
FY13
$254M����� $218M
$885M
29%
Laser Solutions Segment
Leading merchant supplier of CO
2
, Fiber, and
Direct Diode industrial laser components
Leading supplier of CO
2
optics for an install
base of >70,000 high power lasers
First to service EUV Lithography CVD
Diamond optics demand
�
Laser Optics
�
Cutting Heads
�
Semiconductor Laser Chips
�
Ultra-hard Material Processing
�
Laser Source Solutions
Focused on expanding our fiber and direct
diode laser footprint as markets grow |
7
Laser Solutions Segment
Vertical Cavity
Surface Emitting
Laser (VCSEL)
CO
2
Laser Optics
Laser Cutting
Heads
Laser Diode Bar
Green Laser Diode Module |
8
Revenue
TAM
Share
FY14
FY13
$217M����� $141M
$2.0B
11%
Photonics Segment
Worldwide supplier of cutting edge amplification,
pump, and transmission products for optical
communication networks
Service both intercontinental (undersea) and
transcontinental (terrestrial) applications
Leverage vertical integration synergies
to enable a cost structure for market
penetration and growth
�
Precision Optics
�
980nm Pumps
�
Erbium Doped Fiber Amplifiers
�
Optical Switches
�
Optical Coatings and Filters |
9
Source: Worldbank.org -
Based on data from the World Telecommunication/ICT Indicators database
Worldwide Fiber Optic Penetration |
10
Arrayed Amplifiers
Dual Laser Chip
980nm Pumps
40G & 100G Quad Small Form-factor
Pluggable (QSFP) Transceivers
High Performance
Optical Coatings and Filters
Optical Switches
Photonics Segment |
11
Revenue
TAM
Share
FY14
FY13
$213M����� $192M
$2.1B
10%
Focus on strategic markets where II-VI material
expertise and technology enables growth and new
functionality
�
Free Standing Diamond
�
Precision Optical Systems
�
High Value Material Reclamation
�
Reaction Bonded SiC Tools
�
Thermal Management
Target military platforms and applications
with growth potential
Identify emerging markets early and
enable the underpinning materials and
technology
Performance Products Segment |
12
Water Cooled Silicon
Carbide Optics
Energy Harvesting
Pipe Strap
CVD Polycrystalline
Diamond
Large Panel Sapphire
Windows
Opto-mechanical
Assemblies
Performance Products Segment |
13
Gross Margin
EBITDA
Operating Margin
FY15
FY16
35%
-
38%
37%
-
40%
15%
-
18%
19%
-
21%
7%
-
10%
9%
-
12%
Expectations
Margin Performance
Profitability and Expectations
Exiting FY15
200 BPS > Q3 FY14 |
14
Cash and Liquidity
Cash and Equivalents
Cash Flow from Operations
Long-Term Debt
(Including� current� portion)
Shareholders' Equity
FY13
$185M
$108M
$114M
$636M
FY14
$175M
$95M
$241M
$675M
Cash and Liquidity |
15
Company Position
Strong Cash Position
Positive Profit Outlook
Leading Market Positions
Diverse End Markets
Global Manufacturing Footprint
Growth via Organic and Acquisitions
Ongoing $50M Stock Buyback Program |
www.ii-vi.com����� I���� NASDAQ:
IIVI 16
************************* |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
- FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
- HealthStream Survey Discovers Underutilized Opportunity to Recruit Nurses: Student Nurse Rotations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!